Nama Insights
Home
›
Stocks
›
Generate Biomedicines, Inc. (GENB)
Generate Biomedicines, Inc.
(GENB)
Healthcare · Biotechnology · NASDAQ
Generate Biomedicines, Inc. (GENB) is a Healthcare company in the Biotechnology industry. It has a market capitalization of $2.24B and a free-cash-flow yield of -11.4%. Over the most recent reported fiscal year, revenue grew 55.9%.
Market cap
$2.24B
Trailing P/E
—
FCF yield
-11.4%
Revenue growth (YoY)
+55.9%
EPS growth (YoY)
—
FCF/share growth (YoY)
—
Exchange
NASDAQ
Sector
Healthcare
Industry
Biotechnology
Explore live GENB data on Nama Insights →
See more:
Healthcare stocks →
More on Nama Insights
Congress stock trades
Questions and answers
Highest FCF yield stocks
Cheapest stocks by P/E
Fastest revenue growth
Largest US companies
All ETFs